Entrada Therapeutics (TRDA): 10% owner sold ~$280K
MPM BioVentures 2014, 10% owner at Entrada Therapeutics, sold ~$280K of Entrada Therapeutics shares.
- ~$280K
- Approx. value · 39K sh @ $7.20
- 4.28M
- Holds after · shares reported
- Traded
- Aug 27, 2026
- Filed
- Aug 31, 2026
What stands out in this filing
- The sale was 0.9% of the shares this insider held before it; the filing reports 4,279,426 shares, held indirectly afterwards.
- 38,922 shares at an average of $7.20 each, as reported on the form.
- No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jul 30, 2026Insider · 2 peopleInsiders: 2 sales (~$1.6M)
- Jul 31, 2026Insider · 2 peopleInsiders: 2 sales (~$24K)
- Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 6, 2026Insider · 2 peopleInsiders: 2 sales (~$147K)
- Aug 7, 2026Insider · 2 peopleInsiders: 2 sales (~$717K)
- Aug 10, 2026InsiderDirector sold ~$647K of TRDA shares in the open market
- Aug 24, 2026Insider · 2 peopleInsiders: 2 sales (~$317K)
- Aug 25, 2026Insider · 2 peopleInsiders: 2 sales (~$400K)
- Aug 26, 2026Insider · 2 peopleInsiders: 2 sales (~$206K)
- Aug 27, 2026 · this disclosureInsider10% owner sold ~$280K of TRDA shares in the open market
What came next
- Aug 27, 2026Insider10% owner sold ~$280K of TRDA shares in the open market
- Aug 28, 2026Insider · 2 peopleInsiders: 2 sales (~$52K)
- Aug 31, 2026Insider · 2 peopleInsiders: 2 sales (~$619K)
- Sep 1, 2026Insider · 2 peopleInsiders: 2 sales (~$411K)
- Sep 2, 2026Insider · 2 peopleInsiders: 2 sales (~$361K)
- Sep 3, 2026Insider · 2 peopleInsiders: 2 sales (~$463K)
- Sep 4, 2026Insider · 2 peopleInsiders: 2 sales (~$547K)
- Sep 8, 2026Insider · 2 peopleInsiders: 2 sales (~$2.9M)
- Sep 9, 2026Insider · 2 peopleInsiders: 2 sales (~$411K)
- Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Entrada Therapeutics
For Entrada Therapeutics, OQRO holds 24 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TRDA page.
Other recent filings by MPM BioVentures 2014, L.P., 10% owner
- SEC Form 4 at Entrada Therapeutics (TRDA)Sep 9, 2026
- SEC Form 4 at Entrada Therapeutics (TRDA)Sep 9, 2026
- SEC Form 4 at Entrada Therapeutics (TRDA)Sep 9, 2026
- SEC Form 4 at Entrada Therapeutics (TRDA)Sep 3, 2026
- SEC Form 4 at Entrada Therapeutics (TRDA)Sep 3, 2026
The full history of MPM BioVentures 2014, L.P., 10% owner is on the profile page.
How this filing works
Explore the data
Common questions
Which Entrada Therapeutics (TRDA) insider traded, and how much?
MPM BioVentures 2014, 10% owner at Entrada Therapeutics, sold ~$280K of Entrada Therapeutics shares. 39K shares at $7.20.
When did it happen, and when was it made public?
Traded: Aug 27, 2026. Filed: Aug 31, 2026. That is 4 days between the two dates.
What stands out in this filing?
The sale was 0.9% of the shares this insider held before it; the filing reports 4,279,426 shares, held indirectly afterwards. 38,922 shares at an average of $7.20 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Entrada Therapeutics recently?
For Entrada Therapeutics, OQRO holds 24 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the TRDA page.
Does this mean TRDA stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Entrada Therapeutics
- SEC Form 4Sep 9, 2026
- SEC Form 4Sep 9, 2026
- SEC Form 4Sep 9, 2026
- SEC Form 4Sep 9, 2026
- SEC Form 4Sep 9, 2026
- SEC Form 4Sep 9, 2026
Everything OQRO holds on this company is on its TRDA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
